Company
Collagen Matrix
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
18
510(k), De Novo and PMA
Device trials
3
As lead sponsor, any status
Adverse event reports
40
Received Nov 1, 2025 to Nov 20, 2026
Recall records
15
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Collagen Matrix, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
Latest FDA decisions
The 8 newest of 18 since 2015.
K251191 · Decided Nov 18, 2025 · 215 days after receipt
Device type: Dura Substitute (GXQ) · Neurology & Neurosurgery
K243071 · Decided Dec 19, 2024 · 83 days after receipt
Device type: Wound Dressing With Animal-Derived Material(S) (KGN) · General & Plastic Surgery
K242302 · Decided Oct 2, 2024 · 58 days after receipt
Device type: Scaffold, Partial Medial Meniscal Defects Extending Into The Red/White Zone, Resorbable Bovine Collagen (OLC) · General & Plastic Surgery
15 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT04775537 · 120 participants (planned) · Start Jan 21, 2021 · Primary completion Dec 30, 2026
Device: OssiMend™ Bioactive Moldable · For: Spinal Disease; Degenerative Disc Disease
Sites: Encinitas, California; Hartford, Connecticut; Somerset, New Jersey · 4 sites in all
- A Clinical Trial to Evaluate the Safety and Effectiveness of MatrixOssTM Bone GraftPivotal-lookingStatus unknown
NCT05371535 · 188 participants (planned) · Start May 30, 2022 · Primary completion Nov 30, 2022
Device: MatrixOssTM Bone Graft plus Bio-Gide membrane · For: Dental Diseases
- A Clinical Trial to Evaluate the Safety and Effectiveness of Resorbable Collagen Membrane - MatrixflexTMPivotal-lookingStatus unknown
NCT04851847 · 174 participants · Start Jun 10, 2021 · Primary completion Jul 20, 2022
Device: Guided Tissue Regeneration (GTR) · For: Periodontal Diseases; Intrabony Defects; Guided Tissue Regeneration
Sites: Shanghai, China
Reports received
40
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
1
2.5% of reports
Injury reports
39
98% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 3 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 3 | 0 | 0 |
| Mar 24 | 0 | 1 | 0 | 0 |
| Apr 24 | 0 | 2 | 0 | 0 |
| May 24 | 0 | 2 | 0 | 0 |
| Jun 24 | 0 | 3 | 0 | 0 |
| Jul 24 | 0 | 1 | 0 | 0 |
| Aug 24 | 0 | 9 | 0 | 0 |
| Sep 24 | 0 | 1 | 0 | 0 |
| Oct 24 | 0 | 1 | 0 | 0 |
| Nov 24 | 0 | 2 | 0 | 0 |
| Dec 24 | 0 | 1 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 1 | 1 | 0 | 0 |
| Mar 25 | 0 | 1 | 0 | 0 |
| Apr 25 | 0 | 4 | 0 | 0 |
| May 25 | 0 | 1 | 0 | 0 |
| Jun 25 | 0 | 19 | 2 | 0 |
| Jul 25 | 0 | 14 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 6 | 0 | 0 |
| Nov 25 | 0 | 1 | 0 | 0 |
| Dec 25 | 1 | 19 | 0 | 0 |
| Jan 26 | 0 | 4 | 0 | 0 |
| Feb 26 | 0 | 2 | 0 | 0 |
| Mar 26 | 0 | 3 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 1 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 1 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 4 | 0 | 0 |
| Oct 26 | 0 | 4 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
4 more in this ranking with a free account
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1777-2022 · Started Aug 3, 2022 · Posted by FDA Sep 23, 2022
Reason given: The packaging may not be sealed, which could compromise sterility.
Cause as FDA categorized it: Packaging change control · Device type: Wound Dressing With Animal-Derived Material(S) (KGN)
Z-0668-2022 · Started Dec 13, 2021 · Posted by FDA Feb 24, 2022
Reason given: Outer packaging (outer pouch) is not sealed compromising sterility and result in potential risk of patient infection, which could lead to revision surgery
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Dura Substitute (GXQ)
Z-0669-2022 · Started Dec 13, 2021 · Posted by FDA Feb 24, 2022
Reason given: Outer packaging (outer pouch) is not sealed compromising sterility and result in potential risk of patient infection, which could lead to revision surgery
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Dura Substitute (GXQ)
12 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.